The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-Benzyloxyphenyl)-2-(toluene-4-sulfonylamino)acetamide ID: ALA4436814
PubChem CID: 117719069
Max Phase: Preclinical
Molecular Formula: C22H22N2O4S
Molecular Weight: 410.50
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc(S(=O)(=O)NCC(=O)Nc2ccc(OCc3ccccc3)cc2)cc1
Standard InChI: InChI=1S/C22H22N2O4S/c1-17-7-13-21(14-8-17)29(26,27)23-15-22(25)24-19-9-11-20(12-10-19)28-16-18-5-3-2-4-6-18/h2-14,23H,15-16H2,1H3,(H,24,25)
Standard InChI Key: RIBGZQOQQXQJJA-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
40.1497 -16.4965 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.7452 -15.7908 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
39.3362 -16.4939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.0365 -15.3883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4519 -15.3829 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.1612 -15.7889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8674 -15.3776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5766 -15.7835 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.8643 -14.5604 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.2828 -15.3723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9892 -15.7803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6949 -15.3698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6922 -14.5517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9780 -14.1459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2752 -14.5589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0347 -14.5741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3269 -14.1717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6230 -14.5842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6314 -15.4034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3398 -15.8022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9119 -14.1816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3978 -14.1395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
46.1076 -14.5445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.1118 -15.3617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.4028 -15.7699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.4066 -16.5863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.1169 -16.9921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.8248 -16.5755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.8175 -15.7605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
4 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 4 1 0
18 21 1 0
13 22 1 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 410.50Molecular Weight (Monoisotopic): 410.1300AlogP: 3.49#Rotatable Bonds: 8Polar Surface Area: 84.50Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.37CX Basic pKa: ┄CX LogP: 3.80CX LogD: 3.80Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.60Np Likeness Score: -1.60
References 1. (2014) Serine racemase inhibitor,